Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frucht, S.
Right arrow Articles by Fahn, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frucht, S.
Right arrow Articles by Fahn, S.
Neurology 1999;52:1908
© 1999 American Academy of Neurology


Brief Communications

Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole

S. Frucht, MD, J. D. Rogers, MD, P. E. Greene, MD, M. F. Gordon, MD and S. Fahn, MD

From the Columbia-Presbyterian Medical Center (Drs. Frucht, Greene, and Fahn) and Beth Israel Medical Center (Dr. Rogers), New York, NY; and the Long Island Jewish Medical Center (Dr. Gordon), New Hyde Park, NY.

Address correspondence and reprint requests to Dr. S. Frucht, The Neurological Institute, 710 West 168th Street, New York, NY 10032.

The authors report a new side effect of the dopamine agonists pramipexole and ropinirole: sudden irresistible attacks of sleep. Eight PD patients taking pramipexole and one taking ropinirole fell asleep while driving, causing accidents. Five experienced no warning before falling asleep. The attacks ceased when the drugs were stopped. Neurologists who prescribe these drugs and patients who take them should be aware of this possible side effect.




This article has been cited by other articles:


Home page
Br Med BullHome page
C. A. Davie
A review of Parkinson's disease
Br. Med. Bull., June 1, 2008; 86(1): 109 - 127.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. Y. Uc, M. Rizzo, S. W. Anderson, J. D. Sparks, R. L. Rodnitzky, and J. D. Dawson
Impaired navigation in drivers with Parkinson's disease
Brain, September 1, 2007; 130(9): 2433 - 2440.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. M. Biglan, R. G. Holloway Jr, M. P. McDermott, I. H. Richard, and The Parkinson Study Group CALM-PD Investigators
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
Neurology, July 10, 2007; 69(2): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. C. Thannickal, Y.-Y. Lai, and J. M. Siegel
Hypocretin (orexin) cell loss in Parkinson's disease
Brain, June 1, 2007; 130(6): 1586 - 1595.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. D. Gjerstad, G. Alves, T. Wentzel-Larsen, D. Aarsland, and J. P. Larsen
Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
Neurology, September 12, 2006; 67(5): 853 - 858.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
V. Dhawan, D. G. Healy, S. Pal, and K. R. Chaudhuri
Sleep-related problems of Parkinson's disease.
Age Ageing, May 1, 2006; 35(3): 220 - 228.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Avorn, S. Schneeweiss, L. R. Sudarsky, J. Benner, Y. Kiyota, R. Levin, and R. J. Glynn
Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease
Arch Neurol, August 1, 2005; 62(8): 1242 - 1248.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. H. Adler and M. J. Thorpy
Sleep issues in Parkinson's disease
Neurology, June 28, 2005; 64(12_suppl_3): S12 - S20.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
B. K. Plowman, D. T. Boggie, A. P. Morreale, M. G. Schaefer, M. L. DeLattre, and H. Chan
Sleep attacks in patients receiving dopamine-receptor agonists
Am. J. Health Syst. Pharm., March 1, 2005; 62(5): 537 - 540.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Schrag
Driving in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 159 - 159.
[Full Text] [PDF]


Home page
NeurologyHome page
D. B. Rye
The two faces of Eve: Dopamine's modulation of wakefulness and sleep
Neurology, October 26, 2004; 63(8_suppl_3): S2 - S7.
[Abstract] [Full Text]


Home page
NeurologyHome page
K. R. Chaudhuri and P. Martinez-Martin
Clinical assessment of nocturnal disability in Parkinson's disease: The Parkinson's Disease Sleep Scale
Neurology, October 26, 2004; 63(8_suppl_3): S17 - S20.
[Full Text]


Home page
NeurologyHome page
A. H. Schapira
Excessive daytime sleepiness in Parkinson's disease
Neurology, October 26, 2004; 63(8_suppl_3): S24 - S27.
[Full Text]


Home page
NeurologyHome page
P. Barone, M. Amboni, C. Vitale, and V. Bonavita
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease
Neurology, October 26, 2004; 63(8_suppl_3): S35 - S38.
[Abstract] [Full Text]


Home page
NeurologyHome page
A. Bowron
Practical considerations in the use of apomorphine injectable
Neurology, March 23, 2004; 62(6_suppl_4): S32 - S36.
[Abstract] [Full Text]


Home page
NeurologyHome page
B. Phillips
Movement disorders: A sleep specialist's perspective
Neurology, March 9, 2004; 62(90052): S9 - 16.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
A. Razmy, A. E. Lang, and C. M. Shapiro
Predictors of Impaired Daytime Sleep and Wakefulness in Patients With Parkinson Disease Treated With Older (Ergot) vs Newer (Nonergot) Dopamine Agonists
Arch Neurol, January 1, 2004; 61(1): 97 - 102.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
The Parkinson Study Group
A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease
Arch Neurol, December 1, 2003; 60(12): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
S. H. Yale, P. Hansotia, D. Knapp, and J. Ehrfurth
Neurologic Conditions: Assessing Medical Fitness to Drive
Clin. Med. Res., July 1, 2003; 1(3): 177 - 188.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Merino-Andreu, I. Arnulf, E. Konofal, J. P. Derenne, and Y. Agid
Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness
Neurology, May 13, 2003; 60(9): 1553 - 1554.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K R Chaudhuri, S Pal, A DiMarco, C Whately-Smith, K Bridgman, R Mathew, F R Pezzela, A Forbes, B Hogl, and C Trenkwalder
The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. N. Homann, K. Wenzel, K. Suppan, G. Ivanic, N. Kriechbaum, R. Crevenna, and E. Ott
Sleep attacks in patients taking dopamine agonists: review
BMJ, June 22, 2002; 324(7352): 1483 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
O Pogarell, T Gasser, J J van Hilten, S Spieker, S Pollentier, D Meier, and W H Oertel
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study
J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 713 - 720.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. L. Bliwise, D. B. Rye, B. Dihenia, and P. Gurecki
Greater Daytime Sleepiness in Subcortical Stroke Relative to Parkinson's Disease and Alzheimer's Disease
J Geriatr Psychiatry Neurol, June 1, 2002; 15(2): 61 - 67.
[Abstract] [PDF]


Home page
Arch NeurolHome page
P. E. O'Suilleabhain and R. B. Dewey Jr
Contributions of Dopaminergic Drugs and Disease Severity to Daytime Sleepiness in Parkinson Disease
Arch Neurol, June 1, 2002; 59(6): 986 - 989.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Frucht and C. L. Comella
Sudden-Onset Sleep in Parkinson Disease
JAMA, April 24, 2002; 287(16): 2076 - 2077.
[Full Text] [PDF]


Home page
NeurologyHome page
I. Arnulf, E. Konofal, M. Merino-Andreu, J. L. Houeto, V. Mesnage, M. L. Welter, L. Lacomblez, J. L. Golmard, J. P. Derenne, and Y. Agid
Parkinson's disease and sleepiness: An integral part of PD
Neurology, April 9, 2002; 58(7): 1019 - 1024.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. B. Rye and J. Jankovic
Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD
Neurology, February 12, 2002; 58(3): 341 - 346.
[Full Text] [PDF]


Home page
NeurologyHome page
J.J. Ferreira, M. Galitzky, C. Thalamas, M. Tiberge, J.L. Montastruc, C. Sampaio, and O. Rascol
Effect of ropinirole on sleep onset: A randomized, placebo-controlled study in healthy volunteers
Neurology, February 12, 2002; 58(3): 460 - 462.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. K. Tan, S. Y. Lum, S. M.C. Fook-Chong, M. L. Teoh, Y. Yih, L. Tan, A. Tan, and M. C. Wong
Evaluation of somnolence in Parkinson's disease: Comparison with age- and sex-matched controls
Neurology, February 12, 2002; 58(3): 465 - 468.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. P. Hubble
Long-term studies of dopamine agonists
Neurology, February 1, 2002; 58(90001): S42 - 50.
[Abstract] [Full Text]


Home page
NeurologyHome page
C. R. Cantor and M. B. Stern
Dopamine agonists and sleep in Parkinson's disease
Neurology, February 1, 2002; 58(90001): S71 - 78.
[Abstract] [Full Text]


Home page
JAMAHome page
D. E. Hobson, A. E. Lang, W. R. W. Martin, A. Razmy, J. Rivest, and J. Fleming
Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease: A Survey by the Canadian Movement Disorders Group
JAMA, January 23, 2002; 287(4): 455 - 463.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. L. Comella
Daytime Sleepiness, Agonist Therapy, and Driving in Parkinson Disease
JAMA, January 23, 2002; 287(4): 509 - 511.
[Full Text] [PDF]


Home page
NeurologyHome page
S. Frucht, P. E. Greene, W. J. Weiner, C.W. Olanow, R.L. Watts, W.C. Koller, K. Kieburtz, and R. C. Griggs
An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
Neurology, January 8, 2002; 58(1): 156 - 157.
[Full Text] [PDF]


Home page
NeurologyHome page
W. G. Ondo, K. Dat Vuong, H. Khan, F. Atassi, C. Kwak, and J. Jankovic
Daytime sleepiness and other sleep disorders in Parkinson's disease
Neurology, October 23, 2001; 57(8): 1392 - 1396.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Guilleminault and S. N. Brooks
Excessive daytime sleepiness: A challenge for the practising neurologist
Brain, August 1, 2001; 124(8): 1482 - 1491.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. W. Olanow, R. L. Watts, and W. C. Koller
An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Neurology, June 12, 2001; 56(suppl_5): S1 - S88.
[Full Text] [PDF]


Home page
NeurologyHome page
K. Stiasny, J. C. Moller, and W. H. Oertel
Safety of pramipexole in patients with restless legs syndrome
Neurology, November 28, 2000; 55(10): 1589 - 1590.
[Full Text] [PDF]


Home page
JAMAHome page
Parkinson Study Group
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A Randomized Controlled Trial
JAMA, October 18, 2000; 284(15): 1931 - 1938.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. M. Tanner
Dopamine Agonists in Early Therapy for Parkinson Disease: Promise and Problems
JAMA, October 18, 2000; 284(15): 1971 - 1973.
[Full Text] [PDF]


Home page
NEJMHome page
B. C. Hiner, M. Earnhart, T. Yamamoto, S. Frucht, W. J. Weiner, S. A. Factor, O. Rascol, and The 056 Study Group
Ropinirole as Compared with Levodopa in Parkinson's Disease
N. Engl. J. Med., September 21, 2000; 343(12): 884 - 885.
[Full Text]


Home page
NeurologyHome page
I. Arnulf, A.-M. Bonnet, P. Damier, B.-P. Bejjani, D. Seilhean, J.-P. Derenne, and Y. Agid
Hallucinations, REM sleep, and Parkinson's disease: A medical hypothesis
Neurology, July 25, 2000; 55(2): 281 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D J BROOKS
Dopamine agonists: their role in the treatment of Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 685 - 689.
[Full Text] [PDF]


Home page
NEJMHome page
O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, A. E. Lang, and The 056 Study Group
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
N. Engl. J. Med., May 18, 2000; 342(20): 1484 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E.-K. Tan and W. Ondo
Clinical Characteristics of Pramipexole-Induced Peripheral Edema
Arch Neurol, May 1, 2000; 57(5): 729 - 732.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. W. Olanow, A. H. V. Schapira, T. Roth, W. J. Weiner, M. M. Hoehn, A. Lledo, J. Nash, F. M. Arellano, M. Corrigan, G. Arnold, et al.
Falling asleep at the wheel: Motor vehicle mishaps in people taking pramipexole and ropinirole
Neurology, January 11, 2000; 54(1): 274 - 274.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.